GASTROGRAFIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gastrografin, and when can generic versions of Gastrografin launch?
Gastrografin is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in GASTROGRAFIN is diatrizoate meglumine; diatrizoate sodium. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gastrografin
A generic version of GASTROGRAFIN was approved as diatrizoate meglumine; diatrizoate sodium by ADAPTIS on June 27th, 2022.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GASTROGRAFIN?
- What are the global sales for GASTROGRAFIN?
- What is Average Wholesale Price for GASTROGRAFIN?
Summary for GASTROGRAFIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 102 |
| Clinical Trials: | 11 |
| Patent Applications: | 3,266 |
| Drug Prices: | Drug price information for GASTROGRAFIN |
| What excipients (inactive ingredients) are in GASTROGRAFIN? | GASTROGRAFIN excipients list |
| DailyMed Link: | GASTROGRAFIN at DailyMed |
Recent Clinical Trials for GASTROGRAFIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, Los Angeles | Phase 3 |
| Region Skane | Phase 3 |
| Odense University Hospital | Phase 3 |
Pharmacology for GASTROGRAFIN
| Drug Class | Radiographic Contrast Agent |
| Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for GASTROGRAFIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | GASTROGRAFIN | diatrizoate meglumine; diatrizoate sodium | SOLUTION;ORAL, RECTAL | 011245-003 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
